TAYLOR TODD: Open Payments
NPI 1457000945 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 33 payments from 10 companies in 2025. Trend: 2023 $779 · 2024 $708 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $188 |
| Regeneron Healthcare Solutions, Inc. | 3 | $155 |
| GENZYME CORPORATION | 3 | $73 |
| Organogenesis Inc. | 3 | $67 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $67 |
| ABBVIE INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $32 |
| UCB, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $16 |
Products named: TREMFYA, LIBTAYO, DUPIXENT, NOVACHOR, ILUMYA, SKYRIZI, TALTZ, Bimzelx.
Industry payments across SC — which companies pay providers there.
